2,621
Views
18
CrossRef citations to date
0
Altmetric
Research Article

A microemulsion co-loaded with Schizandrin A–docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance

, , , , , & show all
Pages 10-19 | Received 20 Jul 2016, Accepted 15 Aug 2016, Published online: 03 Feb 2017

References

  • Chavanpatil MD , Patil Y , Panyam J. (2006). Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. Int J Pharm 320:150–6
  • Engle MJ , Grove ML , Becich MJ , et al . (1995). Appearance of surfactant-like particles in apical medium of Caco-2 cells may occur via tight junctions. Am J Physiol 268:C1401–13
  • Ferlay J , Soerjomataram I , Dikshit R , et al . (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–86
  • Gottesman MM , Fojo T , Bates SE. (2002). Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48–58
  • Huang M , Jin J , Sun H , et al . (2008). Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae. Cancer Chemother Pharmacol 62:1015–26
  • Jin X , Mo R , Ding Y , et al . (2014). Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance. Mol Pharm 11:145–57
  • Kogashiwa Y , Sakurai H , Kimura T , et al . (2010). Docetaxel suppresses invasiveness of head and neck cancer cells in vitro. Cancer Sci 101:1382–6
  • Li JY , Yu J , Du XS , et al . (2016). Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway. Oncol Rep 36:147–54
  • Markman JL , Rekechenetskiy A , Holler E , et al . (2013). Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv Drug Deliv Rev 65:1866–79
  • Miyawaki Y , Nakajima Y , Kawada K , et al . (2016). Efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy for superficial esophageal squamous cell carcinoma. Dis Esophag [Epub ahead of print]. doi:10.1111/dote.12485
  • Mo R , Jin X , Li N , et al . (2011). The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Biomaterials 32:4609–20
  • Nakatsukasa K , Koyama H , Oouchi Y , et al . (2016a). Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer. Breast Cancer [Epub ahead of print]
  • Nakatsukasa K , Koyama H , Oouchi Y , et al . (2016b). Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer. Breast Cancer [Epub ahead of print]
  • Nomura M , Oze I , Kodaira T , et al . (2016). Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis. Int J Clin Oncol [Epub ahead of print]
  • Pereira JR , Cheng R , Orlando M , et al . (2013). Elderly subset analysis of randomized phase III study comparing pemetrexed plus carboplatin with docetaxel plus carboplatin as first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer. Drugs R&D 13:289–96
  • Puvvada N , Rajput S , Kumar BN , et al . (2015). Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression. Sci Rep 5:11760
  • Qu D , Lin H , Zhang N , et al . (2013). In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery. Carbohydr Polym 92:545–54
  • Qu D , Ma Y , Sun W , et al . (2015). Microemulsion-based synergistic dual-drug codelivery system for enhanced apoptosis of tumor cells. Int J Nanomedicine 10:1173–87
  • Qu D , Sun W , Liu M , et al . (2016). Bitargeted microemulsions based on coix seed ingredients for enhanced hepatic tumor delivery and synergistic therapy. Int J Pharm 503:90–101
  • Shubber S , Vllasaliu D , Rauch C , et al . (2015). Mechanism of mucosal permeability enhancement of CriticalSorb® (Solutol® HS15) investigated in vitro in cell cultures. Pharm Res 32:516–27
  • Sorbe B , Graflund M , Nygren L , et al . (2013). A study of docetaxel weekly or every three weeks in combination with carboplatin as first line chemotherapy in epithelial ovarian cancer: hematological and non-hematological toxicity profiles. Oncol Lett 5:1140–8
  • Strong LE , West JL. (2015). Hydrogel-coated near infrared absorbing nanoshells as light-responsive drug delivery vehicles. ACS Biomater Sci Eng 1:685–92
  • Tew WP , Kelsen DP , Ilson DH. (2005). Targeted therapies for esophageal cancer. Oncologist 10:590–601
  • Wan CK , Zhu GY , Shen XL , et al . (2006). Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells. Biochem Pharmacol 72:824–37
  • Wang C , Guo LB , Ma JY , et al . (2013). Establishment and characterization of a paclitaxel-resistant human esophageal carcinoma cell line. Int J Oncol 43:1607–17
  • Wang S , Yang Y , Wang Y , et al . (2015). Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance. Int J Pharm 495:840–8
  • Wang T , Wang D , Yu H , et al . (2016). Intracellularly acid-switchable multifunctional micelles for combinational photo/chemotherapy of the drug-resistant tumor. ACS Nano 10:3496–508
  • Xiao P , Ma T , Zhou C , et al . (2016). Anticancer effect of docetaxel induces apoptosis of prostate cancer via the cofilin-1 and paxillin signaling pathway. Mol Med Rep 13:4079–84
  • Xu R , Zhang G , Mai J , et al . (2016). An injectable nanoparticle generator enhances delivery of cancer therapeutics. Nat Biotechnol 34:414–18